(Q33331183)

25 July 2017

1 reference

title

Imaging of mild cognitive impairment and early dementia (English)

1 reference

mild cognitive impairment

25 July 2017

0 references

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

N Schuff

1

1 reference

PubMed ID

18445740

25 July 2017

X P Zhu

series ordinal

2

1 reference

PubMed ID

18445740

25 July 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

British Journal of Radiology

25 July 2017

1 reference

25 July 2017

80 Spec No 2

1 reference

25 July 2017

S109-14

1 reference

OLD AGE MENTAL DISORDERS IN NEWCASTLE UPON TYNE. I. A STUDY OF PREVALENCE.

25 July 2017

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Mild cognitive impairment clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

MRI measures of entorhinal cortex vs hippocampus in preclinical AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Mapping hippocampal and ventricular change in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Perfusion abnormalities in prodromal AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Magnetic resonance imaging of perfusion using spin inversion of arterial water

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Correlation between rates of brain atrophy and cognitive decline in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

The Alzheimer's disease neuroimaging initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

Current Epidemiology of Mild Cognitive Impairment and Other Predementia Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F63830887

21 January 2018

Identifiers

DOI

10.1259/BJR/63830887

1 reference

25 July 2017

1 reference

PubMed ID

18445740